Plunkett Research Online: Galapagos NV

GALAPAGOS NV (GLPG) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Galapagos NV is a clinical-stage biotechnology company. The firm specializes in the discovery and development of small molecule medicines with novel modes of action, addressing disease areas of high unmet medical need. Galapagos’ pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery.....


GALAPAGOS NV

Ticker: GLPG
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 32 15342900
Fax: 32 15342901
Address: Generaal De Wittelaan L11 A3
Mechelen, 2800 Belgium

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Onno van de StolpeCEO
Bart FiliusCFO/COO
See More
Galapagos NV is a clinical-stage biotechnology company. The firm specializes in the discovery and development of small molecule medicines with novel modes of action, addressing disease areas of high unmet medical need. Galapagos’ pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery.....See More See More

$USD, In whole numbers 2018201720162015201420132012
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture